|
Parameter
|
Value
|
|---|
|
Age, years
|
50.7 ± 10.2
|
|
Sex
| |
|
Male
|
1497 (85.1%)
|
|
Female
|
263 (14.9%)
|
|
α-Fetoprotein, ng/mL
| |
|
≤ 20
|
726 (41.2%)
|
|
20–400
|
451 (25.6%)
|
|
≥ 400
|
583 (33.1%)
|
|
HBV DNA, IU/ml
| |
|
≤ 1000
|
801 (45.5%)
|
|
> 1000
|
959 (54.5%)
|
|
White blood cells, 109/L
|
5.26 ± 1.74
|
|
Platelet count, 109/L
|
152 (23-479)
|
|
Albumin, g/L
|
41.7 ± 3.74
|
|
Total bilirubin, μmol/L
|
13.4 (3.3–45.4)
|
|
γ-Glutamyl transferase, IU/L
|
55.0 (10–1175)
|
|
Alkaline phosphatase, IU/L
|
80.0 (17–1155)
|
|
ALBI grade
| |
|
≤ − 2.63
|
1270 (72.2%)
|
|
> 2.63
|
490 (27.8%)
|
|
Blood loss, mL
|
|
< 800
|
1650 (93.8%)
|
|
≥ 800
|
110 (6.2%)
|
|
Tumor size, cm
|
5.55 ± 3.48
|
|
Differentiation degree
|
|
I/II
|
295 (16.8%)
|
|
III/IV
|
1465 (83.2%)
|
|
Microvascular invasion
|
|
Absent
|
1354 (76.9%)
|
|
Present
|
406 (23.1%)
|
|
AJCC stage
| |
|
T1a
|
121 (6.9%)
|
|
T1b
|
1250 (71.0%)
|
|
T2
|
389 (22.1%)
|
|
BCLC stage
| |
|
0
|
121 (6.9%)
|
|
A
|
1639 (93.1%)
|
|
Tumor capsule
| |
|
Incomplete/absent
|
1232 (70.0%)
|
|
Complete
|
528 (30.0%)
|
|
Cirrhosis
| |
|
Absent
|
927 (52.7%)
|
|
Present
|
833 (47.3%)
|
- Values shown are mean ± SD, median (range), or n (%)
